These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20415620)

  • 21. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of blood pressure control in hypertensive patients with renal diseases.
    Ohta Y; Tsuruya K; Fujii K; Tokumoto M; Kanai H; Matsumura K; Tsuchihashi T; Hirakata H; Iida M
    Hypertens Res; 2007 Apr; 30(4):295-300. PubMed ID: 17541207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure and survival in the oldest old.
    Oates DJ; Berlowitz DR; Glickman ME; Silliman RA; Borzecki AM
    J Am Geriatr Soc; 2007 Mar; 55(3):383-8. PubMed ID: 17341240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient engagement strategies used for hypertension and their influence on self-management attributes.
    Mc Namara KP; Versace VL; Marriott JL; Dunbar JA
    Fam Pract; 2014 Aug; 31(4):437-44. PubMed ID: 24895137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic impact of the BP DownShift Program on blood pressure control among commercial driver license employees.
    Greene BL; Miller JD; Brown TM; Harshman RS; Richerson GT; Doyle JJ
    J Occup Environ Med; 2009 May; 51(5):542-53. PubMed ID: 19365286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
    Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
    J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of self-measured blood pressure monitoring in a southern rural West Virginia health system.
    Durr AJ; Robinson CH; Seabury RA; Calkins AL; Pollard CR; Thygeson NM; Lindberg CC; McColley JM; Baus AD
    Rural Remote Health; 2023 Oct; 23(4):8248. PubMed ID: 37786248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a tailored health promotion program to reduce cardiovascular disease risk factors among middle-aged and advanced-age bus drivers.
    Hwang GS; Choi JW; Choi SH; Lee SG; Kim KH; Cho YM; Yoon C
    Asia Pac J Public Health; 2012 Jan; 24(1):117-27. PubMed ID: 21247974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological and Lifestyle Factors Associated With Abnormal Blood Pressure in Adolescents Before and After a School-Based Wellness Program in Michigan: A Report From Project Healthy Schools.
    Bernardo S; Krallman R; Kline-Rogers E; Montgomery D; Brown AM; DuRussel-Weston J; Eagle KA; Jackson EA
    J Adolesc Health; 2021 Jul; 69(1):127-133. PubMed ID: 33280975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shift work and arteriosclerosis risk in professional bus drivers.
    Chen CC; Shiu LJ; Li YL; Tung KY; Chan KY; Yeh CJ; Chen SC; Wong RH
    Ann Epidemiol; 2010 Jan; 20(1):60-6. PubMed ID: 19804986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hypertension in bus drivers.
    Ragland DR; Winkleby MA; Schwalbe J; Holman BL; Morse L; Syme SL; Fisher JM
    Int J Epidemiol; 1987 Jun; 16(2):208-14. PubMed ID: 3497118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 single-arm clinical trial.
    Loucks EB; Nardi WR; Gutman R; Kronish IM; Saadeh FB; Li Y; Wentz AE; Webb J; Vago DR; Harrison A; Britton WB
    PLoS One; 2019; 14(11):e0223095. PubMed ID: 31774807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.